EIKN

Eikon Therapeutics, Inc.

Healthcare · Biotechnology

7.30$ -1.1% vs. previous close Closing price · As of: Oct 2, 2026

Statements

Cash Flow

Income Statement Balance Sheet Cash Flow Ratios

Annual Quarterly

Amounts Change % Common size % Per share

Last 12 Full history

Download as CSV

All figures per share in USD.

Tick rows to compare them in a chart (up to 4)

Cash Flow EIKN
Line item	2023	2024	2025
Operating Cash Flow	-3.54	-2.50	-3.48
Depreciation & Amortization	0.33	0.47	0.45
Stock-Based Compensation	0.18	0.23	0.33
Change in Working Capital	0.18	1.49	1.44
Capital Expenditures	0.53	1.57	0.86
Investing Cash Flow	–	–	-3.35
Financing Cash Flow	1.96	0.00	6.50
Change in Cash	0.96	0.31	-0.33
Free Cash Flow	-4.06	-4.07	-4.35

Data as of: October 2, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.